At Novavax, we’ll never rest in our quest to protect the health of people everywhere. This mission guides all we do. Throughout the pandemic, we had one goal in mind: protect the health and wellbeing of people in all corners of the globe. To do this, we have relied on our decades of experience in the vaccines business. We have been privileged to leverage this experience during the COVID-19 pandemic, applying our well-understood protein technology to develop a novel COVID-19 vaccine. At Novavax, we call ourselves SuperNovas and this pandemic is just the latest example of our teams across the globe working tirelessly to develop the tools for a better, healthier world, one where we have vaccines that allow us to address pressing infectious diseases instead of being sidelined by their impact.
In keeping with our mission to protect everyone, we have focused our efforts toward creating a vaccine that will potentially help all individuals, no matter where in the world they live. Because of our focus on creating diverse clinical trial populations and partnering with organizations dedicated to global equitable access, we have kept the health and safety of the most vulnerable at the forefront of our efforts. We have partnered with essential healthcare workers, grassroots organizations, policy makers and governmental bodies across the globe to form a joint effort in providing vaccines to those who need it most.
We are proud to partner alongside some of the biggest names in healthcare at Aspen Ideas: Health 2022. In collaboration with each of you, our hope is to use this time to discuss, counsel and learn how to address the barriers to solving preventable infectious diseases and healthcare inequities. Novavax regularly publishes press releases and statements on our progress at Novavax.com. To learn more about our mission and vision, please follow us on, Facebook, LinkedIn, and Twitter at @Novavax.